1. Home
  2. MRKR vs WKHS Comparison

MRKR vs WKHS Comparison

Compare MRKR & WKHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRKR
  • WKHS
  • Stock Information
  • Founded
  • MRKR N/A
  • WKHS 2007
  • Country
  • MRKR United States
  • WKHS United States
  • Employees
  • MRKR N/A
  • WKHS N/A
  • Industry
  • MRKR Biotechnology: Pharmaceutical Preparations
  • WKHS Auto Manufacturing
  • Sector
  • MRKR Health Care
  • WKHS Consumer Discretionary
  • Exchange
  • MRKR Nasdaq
  • WKHS Nasdaq
  • Market Cap
  • MRKR 21.9M
  • WKHS 22.3M
  • IPO Year
  • MRKR N/A
  • WKHS N/A
  • Fundamental
  • Price
  • MRKR $1.57
  • WKHS $0.49
  • Analyst Decision
  • MRKR Strong Buy
  • WKHS Sell
  • Analyst Count
  • MRKR 1
  • WKHS 3
  • Target Price
  • MRKR $19.00
  • WKHS $5.75
  • AVG Volume (30 Days)
  • MRKR 95.6K
  • WKHS 2.2M
  • Earning Date
  • MRKR 03-25-2025
  • WKHS 03-11-2025
  • Dividend Yield
  • MRKR N/A
  • WKHS N/A
  • EPS Growth
  • MRKR N/A
  • WKHS N/A
  • EPS
  • MRKR N/A
  • WKHS N/A
  • Revenue
  • MRKR $5,395,849.00
  • WKHS $9,097,780.00
  • Revenue This Year
  • MRKR $64.48
  • WKHS N/A
  • Revenue Next Year
  • MRKR N/A
  • WKHS $80.00
  • P/E Ratio
  • MRKR N/A
  • WKHS N/A
  • Revenue Growth
  • MRKR 79.04
  • WKHS N/A
  • 52 Week Low
  • MRKR $1.48
  • WKHS $0.46
  • 52 Week High
  • MRKR $5.99
  • WKHS $7.12
  • Technical
  • Relative Strength Index (RSI)
  • MRKR 35.08
  • WKHS 37.08
  • Support Level
  • MRKR $1.53
  • WKHS $0.49
  • Resistance Level
  • MRKR $1.79
  • WKHS $0.60
  • Average True Range (ATR)
  • MRKR 0.18
  • WKHS 0.05
  • MACD
  • MRKR 0.03
  • WKHS 0.01
  • Stochastic Oscillator
  • MRKR 14.52
  • WKHS 18.04

About MRKR Marker Therapeutics Inc.

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and innovative peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets. It is also developing peptide-based immunotherapeutic vaccines for the treatment of metastatic solid tumors, as well as PolyStart.

About WKHS Workhorse Group Inc.

Workhorse Group Inc is a technology company with a vision to pioneer the transition to zero-emission commercial vehicles. Its focus is to provide sustainable and cost-effective solutions to the commercial transportation sector. It designs and manufactures all-electric delivery trucks and drone systems, including the technology that optimizes the way these vehicles operate. It's focused on a core competency of bringing electric delivery vehicle platforms to serve the last-mile delivery market. Its products are marketed under the Workhorse brand.

Share on Social Networks: